Log In
Print this Print this

RHB-105 (formerly Heliconda)

  Manage Alerts
Collapse Summary General Information
Company RedHill Biopharma Ltd.
DescriptionFixed-dose combination of the antibiotics rifabutin and amoxicillin and the proton pump inhibitor (PPI) omeprazole
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase III
Standard IndicationHelicobacter
Indication DetailsTreat Helicobacter pylori infection
Regulatory Designation U.S. - Fast Track (Treat Helicobacter pylori infection);
U.S. - Qualified Infectious Disease Program (Treat Helicobacter pylori infection)

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today